Word

IVIG IS OUR MIDDLE NAME

Status

Pending

Status Code

730

Status Date

Monday, April 1, 2024

Serial Number

97819809

Mark Type

4000

Filing Date

Thursday, March 2, 2023

Published for Opposition

Tuesday, September 5, 2023

Trademark Owner History

CSL Behring AG - Owner At Publication

Classifications

41 Healthcare education services, namely, conducting educational programs for patients, caregivers and/or healthcare professionals concerning immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; planning and conducting educational conventions and educational meetings related to immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals

16 Printed materials, namely, newsletters, articles and case studies featuring immunoglobulin, immunodeficiency and neurological disorders; Printed publications, namely, brochures, booklets, newsletters, articles, case studies, and teaching materials in the field of immunoglobulin, immunodeficiency and neurological disorders; printed educational materials in the field of immunoglobulin, immunodeficiency and neurological disorders

35 Healthcare education services, namely, promoting awareness of immunoglobulin, immunodeficiency and neurological disorders, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals to patients, caregivers and/or healthcare professionals

44 Providing a website featuring healthcare information in the field of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Healthcare and healthcare information services, namely, providing information concerning immunoglobulin, immunodeficiency and neurological disorders, their treatment and their impact on patients, patient families, caregivers and/or healthcare professionals; Healthcare and healthcare information services, namely, providing information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Providing a website featuring information in the field of the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders; Providing links to the web sites of others featuring information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders

INTRAVENOUS IMMUNOGLOBULIN IS OUR MIDDLE NAME
"IVIG"

Trademark Events

Apr 2, 2024

Notice Of Approval Of Extension Request E-Mailed

Apr 1, 2024

Sou Extension 1 Granted

Apr 1, 2024

Sou Extension 1 Filed

Apr 1, 2024

Sou Teas Extension Received

Oct 31, 2023

Noa E-Mailed - Sou Required From Applicant

Sep 5, 2023

Official Gazette Publication Confirmation E-Mailed

Sep 5, 2023

Published For Opposition

Aug 16, 2023

Notification Of Notice Of Publication E-Mailed

Aug 2, 2023

Approved For Pub - Principal Register

Aug 1, 2023

Teas/Email Correspondence Entered

Aug 1, 2023

Correspondence Received In Law Office

Aug 1, 2023

Teas Response To Office Action Received

May 10, 2023

Notification Of Non-Final Action E-Mailed

May 10, 2023

Non-Final Action E-Mailed

May 10, 2023

Non-Final Action Written

Apr 17, 2023

Assigned To Examiner

Mar 22, 2023

New Application Office Supplied Data Entered

Mar 6, 2023

New Application Entered